Phase I clinical trial to investigate the maximum tolerated dose and pharmacokinetics of liposomal paclitaxel [paclitaxel] with/without capecitabine in Chinese cancer patients with advanced gastric carcinoma.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Capecitabine; Paclitaxel
- Indications Gastric cancer
- Focus Adverse reactions
- Sponsors Nanjing Sike Pharmaceutical
- 18 Apr 2009 Planned end date changed from 1 Dec 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 14 May 2008 Status changed from initiated to in progress.
- 05 Apr 2008 New trial record.